![Valerie Kanter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Kanter
Technik-/Wissenschafts-/F&E-Leiter bei DentaCell Accelerator
Profil
Valerie Kanter has a current job as the Director, Chief Medical & Scientific Officer at DentaCell Accelerator.
Aktive Positionen von Valerie Kanter
Unternehmen | Position | Beginn |
---|---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
DentaCell Accelerator
![]() DentaCell Accelerator Medical SpecialtiesHealth Technology DentaCell Accelerator is an organization that was converted into an accelerator in 2017 to address innovations in dentistry and support multiple startup launches simultaneously. The company is based in Los Angeles, CA. The company provides access to Leonhardt's Launchpads' building IP estate in stem cell, growth factors, micro pumps, and bioelectric stimulation technologies. The company also offers access to Cal-X Stars Business Accelerator, Inc. network of successful entrepreneurs, investors, mentors, and corporate partners. The company focuses on electroceutical treatment of pseudomonas aeruginosa biofilms. The company was founded in 2014, and the CEO is Howard J. Leonhardt. | Health Technology |